Boca Raton, FL - A new meta-analysis of major pravastatin secondary-prevention trials has shown that the benefits from aspirin and statins are additive and may even be synergistic. The authors of the ...

Orlando, FL - Intensive lipid-lowering treatment with atorvastatin (Lipitor ®, Pfizer) 80 mg daily completely halted the progression of atherosclerosis, whereas a moderate lipid-lowering regimen of ...

Hunt D, Young P, Simes J, Hague W, Mann S, Owensby D, et al. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those ...

Three-Year Follow-Up of an Alectinib Phase I/II Study in ALK-Positive Non–Small-Cell Lung Cancer: AF-001JP Patients with confirmed SCLC (limited or extensive disease) and performance status 0 to 3 ...

Older patients without existing atherosclerotic cardiovascular disease do not receive any benefit from statin therapy, according to a new analysis of the lipid-lowering arm of the ALLHAT trial. After ...

The current evidence best supports the use of statin therapy to reduce LDL by 30% or more as the initial strategy to treat CHD patients with low HDL and normal to low LDL The combination of low plasma ...

Nora Pharma's Pravastatin is available in strengths of 10 mg, 20 mg, and 40 mg, and comes in bottles of 100 tablets. According to IQVIA, the Canadian market of cholesterol lowering drugs is estimated ...

Cadila Healthcare Ltd has received tentative approval from the USFDA to market Pravastatin Sodium Tablets in the US market. The tentative approval was given for strengths of 10 mg, 20 mg, 40 mg and 80 ...

Background: An increase in the incidence of cancer among elderly people assigned to pravastatin therapy has been reported in a randomized controlled trial; however, this finding has been attributed to ...

Pravastatin is prescribed for high cholesterol. It's a generic medication, and it's not available as a brand-name drug. It comes as an oral tablet. The cost of pravastatin can vary, but savings are ...

Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPO-I, TOPO-iia, TOPO-iib, and c-MYC genes in patients with small cell lung cancer (SCLC) who received first-line therapy with cisplatin and etoposide.